Carson Wealth (CWM LLC)’s LeMaitre Vascular LMAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$68K Buy
623
+33
+6% +$3.15K ﹤0.01% 3570
2025
Q4
$48K Sell
590
-9
-2% -$775 ﹤0.01% 3638
2025
Q3
$52K Buy
599
+54
+10% +$4.82K ﹤0.01% 3505
2025
Q2
$45K Buy
545
+54
+11% +$4.51K ﹤0.01% 3365
2025
Q1
$41K Sell
491
-18
-4% -$1.67K ﹤0.01% 3142
2024
Q4
$47K Buy
509
+33
+7% +$3.17K ﹤0.01% 2849
2024
Q3
$44K Buy
476
+54
+13% +$4.68K ﹤0.01% 2787
2024
Q2
$35K Buy
422
+76
+22% +$5.58K ﹤0.01% 2724
2024
Q1
$23K Buy
346
+17
+5% +$1.05K ﹤0.01% 2798
2023
Q4
$19K Sell
329
-7
-2% -$367 ﹤0.01% 2802
2023
Q3
$18K Buy
336
+51
+18% +$3.02K ﹤0.01% 2748
2023
Q2
$19K Buy
285
+21
+8% +$1.28K ﹤0.01% 2679
2023
Q1
$14K Buy
264
+27
+11% +$1.31K ﹤0.01% 2746
2022
Q4
$11K Buy
237
+175
+282% +$8.19K ﹤0.01% 2755
2022
Q3
$3K Buy
+62
New +$3.1K ﹤0.01% 3320

Other funds holding LMAT

Carson Wealth (CWM LLC)'s LMAT Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its LeMaitre Vascular (LMAT) stake by 5.6% in Q1 2026, buying an estimated $3.15K and bringing the position to 623 shares worth $68K. The position accounts for ﹤0.01% of the portfolio, ranked #3570.

Carson Wealth (CWM LLC) first reported a position in LMAT in Q3 2022 and has held it in 15 quarters since. 339 funds tracked by Wall St. Rank hold LMAT as of Q1 2026.

  • Carson Wealth (CWM LLC) held 623 shares of LeMaitre Vascular worth $68K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 33 LeMaitre Vascular shares in Q1 2026, an estimated $3.15K.
  • LeMaitre Vascular made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #3570 holding.
  • Carson Wealth (CWM LLC) first reported a position in LeMaitre Vascular in Q3 2022 and has held it in 15 quarters since.
  • 339 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.